David Scheer

David Scheer is an accomplished leader with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving as Chairman of the Board of Directors for several organizations, including Apriligen, Inc., Refactor Health, and BiologicsMD, Inc., David has a long-standing role as President of Scheer & Company, Inc. Additionally, David has held various chairmanship positions in companies such as Adela, Inc., OrphAI Therapeutics, and previously led Revelar Biotherapeutics and Achillion Pharmaceuticals. David's educational background includes an AB degree, cum laude, in Biochemical Sciences from Harvard University and an M.S. in Cell, Molecular and Developmental Biology from Yale University.